Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.

RP

Renol Polychem IPO

Listed SME NSE SME · Specialty Chemicals

Price Band

₹100.0–105.0

Issue Size

₹25.77 Cr

Lot Size

1,200 shares

Min Investment

₹252,000

2 LOTS MIN

GMP

Grey Market Premium — the unofficial premium buyers are currently willing to pay over the issue price once this IPO lists. It's an informal market estimate, not guaranteed, and can move daily right up to listing day. Learn more: GMP vs Kostak vs Sauda →

+₹3.0 (2.86%)

Issue Price

₹105.0

Subject to Sauda

A separate grey-market deal made before allotment is known: a buyer agrees to pay you this amount for your IPO application — but only if you actually get allotted shares. No allotment means no payment either way. This is different from "Kostak," a similarly-named rate that's paid regardless of whether the application gets allotted — TopFund shows the Sauda rate because that's what our data source provides. Learn more: GMP vs Kostak vs Sauda →

₹2700

Paid only if allotted

Renol Polychem IPO AI Summary

  • Renol Polychem IPO is listed on NSE SME in the Specialty Chemicals sector.
  • Price band: ₹100.0–₹105.0 per share, lot size 1,200 shares (min. investment ₹252,000, 2 lots minimum).
  • Subscription window: 31 Jul–04 Aug 2025, listing on 07 Aug 2025.
  • Current GMP is +₹3.0 (2.86%), an estimated listing price of ₹108 — unofficial and can change daily.

Renol Polychem Limited is set to offer its IPO with a focus on expanding its manufacturing capabilities and addressing working capital needs. With a diverse product range and strong management, the company aims to enhance its position in the specialty chemicals sector.

TopFund is not SEBI-registered — this is educational analysis, not personalized investment advice.

Renol Polychem IPO — Third-Party Research Views

Reviews below reflect analyst calls made before this IPO closed on 04 Aug 2025 — not a current signal.

May Apply 25 Jul

Recommendations are sourced from third-party research firms and are not TopFund's own investment advice.

Important Dates

IPO Open Date
Thu, 31 Jul 2025
IPO Close Date
Mon, 04 Aug 2025
Allotment Date
Tue, 05 Aug 2025
Refund Initiation
Wed, 06 Aug 2025
Credit of Shares
Wed, 06 Aug 2025
Listing Date
Thu, 07 Aug 2025
Listing Price
₹108.0 +2.86%

Subscription Status

Subscription data unavailable

Renol Polychem IPO Grey Market Premium (GMP) Today

GMP

+₹3.0

GMP %

+2.86%

Est. Listing

₹108.0

Updated: 25 Jul 2026 14:13

About the Company

Incorporated in 2008, Renol Polychem Limited is a manufacturer and supplier specializing in colour masterbatches, plastic masterbatches, industrial chemicals, impact modifiers, plastic pigments, and more. Their product range includes various color masterbatches such as green, red, yellow, orange, pink, blue, brown, violet, ivory, white, maroon, silver, multicolor, and black, as well as transparent plastic filler masterbatches. The company offers all-in-one additives, including stabilisers, impact modifiers, and colour pigments, to assist manufacturers of UPVC, CPVC pipes, pipe fittings, and other plastic products. Renol Polychem Limited offers a wide variety of masterbatches and polymer solutions, including: Colour Masterbatches Green, Red, Yellow, Orange, Pink, Blue, Brown, Violet, Ivory, White, Maroon, Silver, Multicolor, and Black Masterbatches. Specially formulated masterbatches for plastic moulding, extrusion, and film applications. Filler Masterbatches Transparent Plastic Filler Masterbatches Talc and Calcium Carbonate-based filler masterbatches for improving cost efficiency and mechanical properties in plastic production. Additive Masterbatches UV Stabilizers Antioxidants Slip & Anti-block Agents Processing Aids Flame Retardants. Polymer Compounds & Pigments High-performance plastic pigments Polymer modifiers to enhance strength, flexibility, and durability. The company's products find application in industries such as plastic packaging (flexible and rigid), Automotive Components, Household & Consumer Goods, Electrical & Electronics, Textiles & Fibers and Agricultural Films & Pipes. As of September 30, 2024, the company had 15 employees in various departments. Competitive Strength: Rich management experience. Diversified product range appealing to a wide range of customers. Cordial relationship with the customers/ vendors and established manufacturing facility.

Company Financials (₹ Cr)

As of 2025-05-31

Period Ended 31 May 2025 31 Mar 2025 31 Mar 2024 31 Mar 2023
Assets 25.86 23.41 15.49 10.28
Total Income 12.02 62.56 6.52 41.86
Profit After Tax 1.14 5.00 1.53 0.73
EBITDA 1.60 7.07 2.18 1.14
NET Worth 14.47 13.33 8.69 2.71
Reserves and Surplus 8.98 7.84 3.20
Total Borrowing 5.28 6.95 2.58 5.36

Key Ratios

EPS

₹9.10

NAV

₹24.28

ROE

45.37%

ROCE

64.18%

RoNW

45.37%

P/B Value

4.32

P/E Ratio

11.54

Market Cap

₹83.41 Cr

PAT Margin

8.02%

Debt/Equity

0.52

Peer Comparison

Company NAV RoNW P/E (x) EPS Basic EPS Diluted
R M Drip and Sprinklers Systems 32 41.45% 63.69 9.58 9.58
Captain Polyplast 25.5 25.4% 15.07 5.28 5.28
Multibase India 62.21 13.76% 23.85 11.61 11.61
Renol Polychem This IPO 24.28 45.37% — 9.1 9.1

Promoters

Bhaveshbhai Mansukhbhai Harsoda and Naitik Bhaveshbhai Harshoda

Objects of the Issue

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Capital Expenditure in requirements for the purchase of Machinery 5.60 2 Repayment of certain borrowings 1.00 3 To meet out the Working Capital Requirements 15.15 4 General Corporate Purposes 0.96 5 Issue Expenses 3.06 Total 25.77

IPO Evaluation

Generated 23 Sep 2026

Revenue Trend

Total income was ₹41.86 Cr in the period ending 31 Mar 2023, rising to ₹6.52 Cr by 31 Mar 2024. However, income increased significantly to ₹62.56 Cr by 31 Mar 2025, before dropping to ₹12.02 Cr in the latest period ending 31 May 2025, though this is a 9-month figure, not a full year, so isn't directly comparable.

Profit Trend

Profit after tax was ₹0.73 Cr in the period ending 31 Mar 2023, increasing to ₹1.53 Cr by 31 Mar 2024. This rose further to ₹5.00 Cr by 31 Mar 2025, but then decreased to ₹1.14 Cr in the latest period ending 31 May 2025, though this is a 9-month figure, not a full year, so isn't directly comparable.

Valuation

Priced at a P/E ratio of 11.54 at the issue price of ₹105.0, this is lower than peers such as R M Drip and Sprinklers Systems, which trades at a P/E of 63.69, and Captain Polyplast at 15.07.

Grey Market Premium, Explained

The Grey Market Premium (GMP) indicates the expected listing price of an IPO compared to its issue price. A positive GMP suggests that the stock may list at a higher price than the issue price, reflecting demand in the grey market.

Who This IPO Suits

Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their overall investment strategy, considering the company's fundamentals and market conditions.

Who May Want to Wait

Investors who are risk-averse or prefer stable, established companies may want to avoid this IPO, as it involves exposure to the uncertainties of a growing company in the specialty chemicals sector.

IPO Timeline, Explained

The IPO opens for subscription on July 31, 2025, and closes on August 4, 2025. Allotment of shares will be done on August 5, 2025, and the shares are expected to be listed on the stock exchange on August 7, 2025.

Listing Gains — The Risk

While many investors hope for listing gains, these can be unpredictable. Factors such as market conditions and investor sentiment can significantly affect the stock's performance on its debut day.

This evaluation is generated from Renol Polychem's own public IPO filing data for educational purposes and is not investment advice or a recommendation to apply, subscribe to, or avoid this issue — see Broker Recommendations below for named third-party research views (clearly attributed, not TopFund's own). TopFund is not a SEBI-registered investment adviser — see our Disclaimer.

Frequently Asked Questions

What is Renol Polychem IPO GMP today?

Renol Polychem IPO GMP today is +₹3.0 (2.86%), indicating an estimated listing price of ₹108. GMP is an unofficial grey-market indicator and can change daily.

What is the price band of Renol Polychem IPO?

The price band of Renol Polychem IPO is ₹100.0–₹105.0 per share.

When does Renol Polychem IPO open and close?

Renol Polychem IPO opens on 31 July 2025 and closes on 04 August 2025.

When does Renol Polychem IPO list on the stock exchange?

Renol Polychem IPO listed on 07 August 2025 at ₹108.0.

What is the lot size for Renol Polychem IPO?

The lot size for Renol Polychem IPO is 1200 shares, requiring a minimum investment of ₹252,000 (2 lots).

What is the price band for the IPO?

The price band for the IPO is ₹100.0 to ₹105.0.

What is the minimum investment required?

The minimum investment required is ₹252,000.

What is the lot size for the IPO?

The lot size for the IPO is 1200 shares.

When is the listing date?

The listing date is expected to be August 7, 2025.

What does GMP mean?

GMP stands for Grey Market Premium, which indicates the expected premium or discount of the stock's listing price compared to its issue price.

Issue Details

Issue Type SME Book Built
Issue Size ₹25.77 Cr
Price Band ₹100.0 – ₹105.0
Issue Price ₹105.0
Lot Size 1,200 shares
Min Investment ₹252,000 (2 lots minimum)
Exchange NSE SME
Sector Specialty Chemicals
Open Date 31 Jul 2025
Close Date 04 Aug 2025
Allotment 05 Aug 2025
Listing Date 07 Aug 2025

Investor Allocation

QIB (Institutional) 50%
NII / HNI 15%
Retail (RII) 35%

Registrar

Skyline Financial Services Pvt.Ltd.

Lead Managers / Book Running

Corporate Makers Capital Ltd.

IPO Timeline

Open

31 Jul 2025

Close

04 Aug 2025

Allotment

05 Aug 2025

Listing

07 Aug 2025

Community Sentiment

What are other investors planning for Renol Polychem?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

No comments yet — start the discussion.